Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Non-Current Deffered Revenue (2020)

Historic Non-Current Deffered Revenue for Burning Rock Biotech (BNR) over the last 1 years, with Q4 2020 value amounting to $40000.0.

  • Burning Rock Biotech's Non-Current Deffered Revenue changed N/A to $40000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $40000.0, marking a year-over-year change of. This contributed to the annual value of $40000.0 for FY2020, which is N/A changed from last year.
  • Burning Rock Biotech's Non-Current Deffered Revenue amounted to $40000.0 in Q4 2020.
  • In the past 5 years, Burning Rock Biotech's Non-Current Deffered Revenue ranged from a high of $40000.0 in Q4 2020 and a low of $37000.0 during Q2 2020